Daniel Lin study shows two biomarkers in urine are associated with cancers likely to be aggressive among men who take a 'watchful waiting' approach
Feb. 6, 2012
| By Kristen Woodward
Initial results of a multicenter study coordinated by Hutchinson Center researchers indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance, approach to manage their disease. Ultimately, these markers may lead to the development of a urine test that could complement prostate biopsy for predicting disease aggressiveness and progression.
Richard Zager and colleagues link key markers to early detection of renal failure
Nov. 15, 2010
Lead author Dr. Richard Zager of the Fred Hutchinson Cancer Research Center's Clinical Research Division, with Dr. Ali Johnson in his lab and colleagues from UW Medicine, Seattle Children’s and Vanderbilt University Medical Center, investigated whether certain molecules that are produced during injury and infection might be excreted in the urine and serve as diagnostic markers.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.